Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus

Fawsitt CG., Vickerman P., Cooke GS., Barnes E., Ball J., Brainard D., Burgess G., Cooke GS., Dillon J., Foster G., Gore C., Guha N., Halford R., Whitby K., Holmes C., Howe A., Hudson E., Hutchinson S., Irving W., Khakoo S., Klenerman P., Martin N., Massetto B., Mbisa T., McHutchison J., McKeating J., McLauchlan J., Miners A., Murray A., Shaw P., Simmonds P., Spencer C., Thomson E., Vickerman P., Zitzmann N., Welton NJ.

DOI

10.1016/j.jval.2019.08.012

Type

Journal article

Journal

Value in Health

Publisher

Elsevier BV

Publication Date

02/2020

Volume

23

Pages

180 - 190

Permalink Original publication